已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Complications after treatment of type B aortic dissection with TEVAR stent-graft deployment in zone 2

医学 血管病学 心脏外科 主动脉夹层 外科 心胸外科 支架 解剖(医学) 血管外科 心脏病学 放射科 主动脉
作者
Xiao-Biao Zhou,Xin Chen,Zhan Wang,Ding-Qiang Chen,Rui P. Li,Li Li,Lichao Xu,Zhihuang Chen,Man Shu Song,Jian Huang,Jia-Wei Zhuang,Gang-Yi Cheng,Qingxin Xu,Zhuang-Hui Zhu,Zhonggui Shan
出处
期刊:BMC Cardiovascular Disorders [BioMed Central]
卷期号:25 (1): 91-91 被引量:6
标识
DOI:10.1186/s12872-025-04533-x
摘要

To analyze the outcome of 147 cases of type B aortic dissection with thoracic endovascular aortic repair (TEVAR). We systematically reviewed 147 patients of type B aortic dissection with stent graft deployment in zone 2 or zone 3 by TEVAR from January 2012 to December 2022. These patients were observed by computed tomography angiography after the first and third months and annually thereafter during follow-up. Statistical analysis was performed by SPSS.16. The stent graft of 107 patients was deployed in zone 3, and the stent graft of 40 patients was deployed in zone 2. Severe dissection and surgery-related complications after TEVAR occurred in 19 patients, with complications arising more frequently in zone 2 than in zone 3 (12/40 vs. 7/107, P < 0.005). Endoleak was detected in 10 (6.8%, 10/147) cases, which included 6 cases of endoleak in zone 2, exceeding the 4 cases of endoleak in zone 3 (6/40 vs. 4/107, P < 0.05). Twelve (8.16%, 12/147) cases underwent re-intervention, and the 8 patients who underwent re-intervention in zone 2 exceeded the 4 patients who underwent re-intervention in zone 3 (8/40 vs. 4/107, P < 0.05). One case of subclavian steal in zone 2 (0.68%, 1/147). Two (1.36%, 2/147) cases died after TEVAR. The 1-year, 3-year, and 5-year overall survival rates were 99.3%, 98.6%, and 98.6%, respectively. The re-intervention rates were 5.4%, 7.5%, and 8.2%, respectively. The re-intervention rates in zone 2 were 15%, 20%, and 20%, respectively. The re-intervention rates in zone 3 were 1.9%, 2.8%, and 3.7%, respectively. TEVAR is the major treatment to use if the stent graft can be deployed in zone 3. However, with the higher rate of complications and re-intervention after TEVAR, for patients whose stent graft can only be deployed in zone 2, it is not recommended that TEVAR be chosen as the preferred treatment. Type of Research: Single-center retrospective cohort study. Key findings: 147 patients of type B aortic dissection with stent graft deployed in zone 2 or zone 3 by TEVAR. Severe dissection and surgery-related complications after Thoracic EndoVascular Aortic Repaie (TEVAR) occurred in 19 patients, with complications arising more frequently in zone 2 than in zone 3 (12/40 vs. 7/107, P < 0.005). Endoleak was detected in 10 (6.8%, 10/147) cases, which included 6 cases of endoleak in zone 2, exceeding the 4 cases of endoleak in zone 3 (6/40 vs. 4/107, P < 0.05). Twelve (8.16%, 12/147) cases underwent re-intervention, and the 8 patients who underwent re-intervention in zone 2 exceeded the 4 patients in zone 3 (8/40 vs. 4/107, P < 0.05). The 1-year, 3-year, and 5-year overall survival rates were 99.3%, 98.6%, and 98.6%, respectively. The re-intervention rates were 5.4%, 7.5%, and 8.2%, respectively. The re-intervention rates in zone 2 were 15%, 20%, and 20%, respectively. The re-intervention rates in Zone 3 were 1.9%, 2.8%, and 3.7%, respectively. Take Home Message: This study suggests that TEVAR is the major treatment to use TEVAR if the stent graft can be deployed in zone 3. However, with the higher rate of complications and re-intervention after TEVAR, for patients whose stent graft can only be deployed in zone 2, it is not recommended that TEVAR be chosen as the preferred treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pik完成签到,获得积分20
2秒前
五岳三鸟完成签到,获得积分10
2秒前
摇摇晃晃完成签到 ,获得积分10
3秒前
3秒前
3秒前
4秒前
5秒前
SciGPT的应助被手提袋子的猫采纳,获得10
5秒前
6秒前
长情的寇完成签到 ,获得积分10
6秒前
77完成签到,获得积分10
6秒前
6秒前
7秒前
木华发布了新的文献求助10
8秒前
8秒前
胡图图完成签到 ,获得积分20
8秒前
酷波er的应助被无情妙菡采纳,获得10
9秒前
9秒前
科研通AI6.3的应助被积极北上采纳,获得10
9秒前
时老完成签到 ,获得积分10
10秒前
10秒前
Parker发布了新的文献求助10
12秒前
12秒前
hmv发布了新的文献求助10
13秒前
Arvin发布了新的文献求助10
13秒前
ar发布了新的文献求助10
14秒前
魏魏完成签到,获得积分10
14秒前
14秒前
zhzhzh发布了新的文献求助10
15秒前
Owen的应助被杨家南采纳,获得10
16秒前
16秒前
不吃鸭梨完成签到,获得积分10
18秒前
砍柴少年发布了新的文献求助10
18秒前
无限的含羞草完成签到,获得积分10
19秒前
20秒前
清风携来春夏完成签到,获得积分10
21秒前
Ava的应助被谦让的语儿采纳,获得10
21秒前
OK的应助被林夕采纳,获得80
21秒前
砰砰里完成签到,获得积分10
22秒前
阿狸完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179104
求助须知:如何正确求助?哪些是违规求助? 9569680
关于积分的说明 21806134
捐赠科研通 7774263
什么是DOI,文献DOI怎么找? 3433003
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478643